Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Idec acquires rights to anticancer agent

Feb. 13, 1997

Basal lamina-based drugs offer promise for tumor metastasis

Feb. 13, 1997

Supplemental NDA filed for Photofrin

Feb. 13, 1997

Orphan Medical expands clinical trials of Busulfanex

Feb. 13, 1997

Sugen reports modulators of tyrosine signal transduction

Feb. 13, 1997

Anticancer agents from Takeda

Feb. 13, 1997

Antineoplastic retinoid compounds disclosed

Feb. 12, 1997

U.K. launch for SKB anticancer treatment

Feb. 11, 1997

Tanabe selects ellipticine derivative for further development

Feb. 11, 1997

Eisai synthesizes heterocyclic anticancer compounds

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...